On July 16th, when BAFNA Pharma was at 45, I had written: BAFNA Pharma is a good company and is trying to make its mark. The charts show the formation of a classic head-and-shoulder pattern with 54 being the head; price will correct to around 42 levels and form a base for some time. But it is reasonable to expect that it will cross 50-52 in the next 3-4 months.
And that is exactly what happened: BAFNA slipped and consolidated around 42 between July 30th and Aug 8th and then started showing some strength. It touched 57.70 on Nov 11th. Currently at 49. One can buy this script in small quantities around 48-49 for a 6 month target of 62.
No comments:
Post a Comment